Giant-cell tumor of bone
giant cell tumor and bone cancer and bone tissue neoplasm that results in the presence of multinucleated giant cells (osteoclast-like cell)
Giant-cell tumor of the bone (GCTOB) is a relatively uncommon bone tumor characterized by the presence of multinucleated giant cells (osteoclast-like cells). Malignancy in giant-cell tumor is uncommon and occurs in about 2% of all cases. However, if malignant degeneration does occur, it is likely to metastasize to the lungs. Giant-cell tumors are normally benign, with unpredictable behavior.
It is a heterogeneous tumor composed of different cell populations. The giant-cell tumour stromal cells (GCTSC) constitute the neoplastic cells, which are from a mesenchymal stem cell origin and are classified based on expression of osteoblast cell markers such as alkaline phosphatase and osteocalcin. In contrast, the mononuclear osteoclast precursor cells giving rise to multinucleated giant cells (MNGC) are secondarily recruited and comprise the non-neoplastic cell population. They are derived from an hematopoietic monocyte/ macrophage lineage determined primarily by expression of CD68, a marker for monocytic precursor cells. In most patients, the tumors are slow to develop, but may recur locally in as many as 50% of cases.
Signs and symptoms
Patients usually present with pain and limited range of motion caused by tumor's proximity to the joint space.
Begin with the source’s own compact description: “Giant-cell tumor of bone” is giant cell tumor and bone cancer and bone tissue neoplasm that results in the presence of multinucleated giant cells (osteoclast-like cell). The dossier treats that line as a proposition to test through Giant-cell, tumor and bone, not as a finished interpretation.
Why this record matters
The phrase “giant cell tumor and bone cancer and bone tissue neoplasm that results in the presence of multinucleated giant cells (osteoclast-like cell)” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Sep 23, 2026. The linked authority identifier is Q1785791. None of the 0 selected statements returned an explicit reference.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Giant-cell tumor of bone”, its source revision and the description used here.
- Expand the search: follow Giant-cell tumor of bone primary sources, Giant-cell tumor of bone archive and Giant-cell research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Giant-cell tumor of bone”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Giant-cell tumor of bone” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.